ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 13151 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 13151; 2) Community: the network communities that were significantly associated with the response to NSC 13151; 3) Molecule: the relationships between components within communities and NSC 13151; 4) MDR: the compounds that were significantly associated with the NSC 13151.

NSC Compound Enrichment Correlation
NSC 732698 1-{4-[4-chloro-1-(2,4-dichlorobenzyl)-2,5-dioxo-2,5-dihydro- 1H-3-pyrrolylamino]phenylcarboxamido}-3-trifluoromethylbenze ne 0.0396077140933377 0.47631594
NSC 736081 4-morpholin-4-yl-6[(Z)-2-(5-nitro-thiophen-2-yl)ethenyl]-1,3 ,5-triazin-2-ylamine 0.0396077140933377 0.31838523
NSC 743432 2-{5-[4-(5-{4-[6-morpholino-1H-benzo[d]imidazole-2-yl]phenoxy}pentyl)piperazino]pentyl}-2,3-dihydro-1H-benzo[de]isoquinoline-1,3-dione 0.0396077140933377 0.52264917
NSC 117281 ANTINEOPLASTIC-117281 0.039607714093338 0.50347854
NSC 148077 Null 0.0403978426119736 0.42971196
NSC 177382 TUNICAMYCIN 0.0403978426119736 -0.11753925
NSC 208734 ACLACINOMYCIN A 0.0403978426119736 0.34416443
NSC 225112 2,4,6-Quinazolinetriamine, N(6)-[(3,4-dichlorophenyl)methyl]-N(6)-ethyl-5-methyl- 0.0403978426119736 0.16085077
NSC 373355 Saframycin R 0.0403978426119736 0.39122281
NSC 381811 Poly(oxy-1,2-ethanediyl), .alpha.-methyl-.omega.-[[3- (5-fluoro-1,2,3,4-tetrahydro-2,4-dioxo-1-pyrimidinyl)- 1-oxopropyl]oxy]- 0.0403978426119736 0.31187476
Total:107  Current:94    [First] [Prev] [Next] [Last]